Progyny, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Progyny, Inc. (PGNY) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $21.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-07
- Progyny, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $21.18M, a 35.97% decline year-over-year.
- Progyny, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $20.36M, a 38.34% decline year-over-year.
- Progyny, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $35.53M, a 12.62% increase year-over-year.
- Progyny, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $33.02M, a 1.36% decline year-over-year.
- Progyny, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $134.63M, a 3.93% increase from fiscal 2024.
- Progyny, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $129.54M, a 5.14% increase from fiscal 2023.
- Progyny, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $123.21M, a 21.36% increase from fiscal 2022.
- Progyny, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $101.52M, a 200.46% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $21.18M 10-Q · filed 2026-08-07 | $41.53M 10-Q · filed 2026-08-07 | $77.06M derived: sum of 3 quarters · filed 2026-08-07 | $110.08M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $20.36M 10-Q · filed 2026-05-08 | $55.88M derived: sum of 2 quarters · filed 2026-05-08 | $88.90M derived: sum of 3 quarters · filed 2026-05-08 | $121.98M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $35.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $68.55M derived: sum of 2 quarters · filed 2026-02-27 | $101.62M derived: sum of 3 quarters · filed 2026-08-07 | $134.63M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $33.02M 10-Q · filed 2025-11-07 | $66.09M derived: sum of 2 quarters · filed 2026-08-07 | $99.10M 10-Q · filed 2025-11-07 | $130.65M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $33.07M 10-Q · filed 2026-08-07 | $66.08M 10-Q · filed 2026-08-07 | $97.63M derived: sum of 3 quarters · filed 2026-08-07 | $131.10M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $33.01M 10-Q · filed 2026-05-08 | $64.56M derived: sum of 2 quarters · filed 2026-05-08 | $98.03M derived: sum of 3 quarters · filed 2026-05-08 | $131.35M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $31.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $65.02M derived: sum of 2 quarters · filed 2026-02-27 | $98.34M derived: sum of 3 quarters · filed 2026-02-27 | $129.54M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $33.47M 10-Q · filed 2025-11-07 | $66.79M derived: sum of 2 quarters · filed 2025-11-07 | $98.00M 10-Q · filed 2025-11-07 | $126.95M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $33.32M 10-Q · filed 2025-08-08 | $64.53M 10-Q · filed 2025-08-08 | $93.48M derived: sum of 3 quarters · filed 2026-02-27 | $124.89M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $31.21M 10-Q · filed 2025-05-09 | $60.16M derived: sum of 2 quarters · filed 2026-02-27 | $91.57M derived: sum of 3 quarters · filed 2026-02-27 | $123.47M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $28.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $60.36M derived: sum of 2 quarters · filed 2026-02-27 | $92.26M derived: sum of 3 quarters · filed 2026-02-27 | $123.21M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $31.41M 10-Q · filed 2024-11-12 | $63.30M derived: sum of 2 quarters · filed 2024-11-12 | $94.25M 10-Q · filed 2024-11-12 | $123.83M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | $31.90M 10-Q · filed 2024-08-07 | $62.85M 10-Q · filed 2024-08-07 | $92.42M derived: sum of 3 quarters · filed 2025-03-03 | $115.84M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | $30.95M 10-Q · filed 2024-05-10 | $60.52M derived: sum of 2 quarters · filed 2025-03-03 | $83.94M derived: sum of 3 quarters · filed 2025-03-03 | $107.77M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2022-12-31 | $29.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $53.00M derived: sum of 2 quarters · filed 2025-03-03 | $76.82M derived: sum of 3 quarters · filed 2025-03-03 | $101.52M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $23.42M 10-Q · filed 2023-11-08 | $47.24M derived: sum of 2 quarters · filed 2023-11-08 | $71.94M 10-Q · filed 2023-11-08 | $86.99M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $23.82M 10-Q · filed 2023-08-04 | $48.52M 10-Q · filed 2023-08-04 | $63.57M derived: sum of 3 quarters · filed 2024-02-29 | $70.75M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $24.70M 10-Q · filed 2023-05-09 | $39.75M derived: sum of 2 quarters · filed 2024-02-29 | $46.93M derived: sum of 3 quarters · filed 2024-02-29 | $53.46M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $15.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $22.23M derived: sum of 2 quarters · filed 2024-02-29 | $28.75M derived: sum of 3 quarters · filed 2024-02-29 | $33.79M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $7.18M 10-Q · filed 2022-11-04 | $13.71M derived: sum of 2 quarters · filed 2022-11-04 | $18.74M 10-Q · filed 2022-11-04 | $22.90M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $6.53M 10-Q · filed 2022-08-05 | $11.56M 10-Q · filed 2022-08-05 | $15.72M derived: sum of 3 quarters · filed 2023-03-01 | $18.79M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $5.03M 10-Q · filed 2022-05-06 | $9.19M derived: sum of 2 quarters · filed 2023-03-01 | $12.27M derived: sum of 3 quarters · filed 2023-03-01 | $15.81M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $7.23M derived: sum of 2 quarters · filed 2023-03-01 | $10.77M derived: sum of 3 quarters · filed 2023-03-01 | $12.82M 10-K · filed 2023-03-01 | -$12.82M 10-K · filed 2021-03-01 |
| 2020-09-30 | $3.07M 10-Q · filed 2021-11-08 | $6.61M derived: sum of 2 quarters · filed 2021-11-08 | $8.66M 10-Q · filed 2021-11-08 | $10.51M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $3.54M 10-Q · filed 2021-08-06 | $5.59M 10-Q · filed 2021-08-06 | $7.44M derived: sum of 3 quarters · filed 2022-03-01 | $9.12M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $2.05M 10-Q · filed 2021-05-07 | $3.90M derived: sum of 2 quarters · filed 2022-03-01 | $5.58M derived: sum of 3 quarters · filed 2022-03-01 | $6.59M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.53M derived: sum of 2 quarters · filed 2022-03-01 | $4.54M derived: sum of 3 quarters · filed 2022-03-01 | $5.06M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $1.68M 10-Q · filed 2020-11-06 | $2.69M derived: sum of 2 quarters · filed 2020-11-06 | $3.21M 10-Q · filed 2020-11-06 | $3.90M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $1.01M 10-Q · filed 2020-08-07 | $1.53M 10-Q · filed 2020-08-07 | $2.22M derived: sum of 3 quarters · filed 2021-03-01 | $3.02M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $517.00K 10-Q · filed 2020-05-14 | $1.21M derived: sum of 2 quarters · filed 2021-03-01 | $2.01M derived: sum of 3 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $693.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.49M derived: sum of 2 quarters · filed 2021-03-01 | $3.00M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $796.00K 10-Q · filed 2019-12-06 | $2.30M 10-Q · filed 2019-12-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |